-

Shareholder Alert: Robbins LLP Reminds Investors of Class Action Lawsuit Against Oak Street Health, Inc. (OSH)

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Oak Street Health, Inc. (NYSE: OSH) securities between August 6, 2020 and November 8, 2021. Oak Street purportedly operates primary care centers in the U.S.

If you suffered a loss due to Oak Street Health, Inc.'s misconduct, click here.

Oak Street Health, Inc. (OSH) is Being Investigated for Violating the False Claims Act

According to the complaint, on November 8, 2021, Oak Street disclosed that on November 1, 2021, the Company received a civil investigative demand ("CID") from the U.S. Department of Justice ("DOJ"). According to the CID, the DOJ was investigating whether the Company violated the False Claims Act. The CID also requests documents and information related to Oak Street's relationships with "third-party marketing agents" and Oak Street's "provision of free transportation to federal health care beneficiaries." On this news, the Company's stock price fell $9.75, or more than 20%, to close at $37.14 per share on November 9, 2021.

The complaint alleges that during the class period, defendants failed to disclose facts about the Oak Street's business, including that it maintained relationships with third-party marketing agents likely to provoke law enforcement scrutiny and was providing free transportation to federal health care beneficiaries in a manner that would provoke law enforcement scrutiny. Because these activities may be violations of the False Claims Act, Oak Street was at a heightened risk of investigation by the DOJ and/or other federal law enforcements agencies and was subject to adverse impacts related to defense and settlement costs and diversion of management resources.

If you purchased shares of Oak Street Health, Inc. (OSH) between August 6, 2020 and November 8, 2021, you have until March 11, 2022, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:
Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Oak Street Health, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:OSH

Release Summary
Oak Street Health, Inc. (OSH) is Being Investigated for Violating the False Claims Act
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investment Notice: Robbins LLP Informs Investors of the Megan Holdings Limited Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Megan Holdings Limited (NASDAQ: MGN) securities between September 26, 2025 and March 25, 2026, or acquired shares in connection with its initial public offering ("IPO") on September 26, 2025. The Company conducts its purported business operations in Malaysia and purportedly is principally engaged in the development, construction, and maintenanc...

Investor Notice: Robbins LLP Informs Investors of the Photronics, Inc. Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Photronics, Inc. (NASDAQ: PLAB) securities between December 10, 2025 and May 27, 2026. Photronics is a global manufacturer of photomasks, which are microscopic circuit patterns contained on very precise glass or quartz plates, and which are a necessary element in the manufacturing of integrated circuits (“ICs”) and flat panel displays (“FPDs”)....

Investor Notice: Robbins LLP Informs Investors of the Insulet Corporation Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Insulet Corporation (NASDAQ: PODD) securities between February 21, 2025 and May 26, 2026. Insulet develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the U.S. and internationally. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The A...
Back to Newsroom